Literature DB >> 19418667

BCG vaccination in South African HIV-exposed infants--risks and benefits.

A C Hesseling1, J Caldwell, M F Cotton, B S Eley, H B Jaspan, K Jennings, B J Marais, J Nuttall, H Rabie, P Roux, H S Schaaf.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19418667      PMCID： PMC2869300     

Source DB:  PubMed          Journal:  S Afr Med J


× No keyword cloud information.
  17 in total

1.  Global Advisory Committee on Vaccine Safety, 29-30 November 2006.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2007-01-19

2.  Meeting of the immunization Strategic Advisory Group of Experts, April 2007--conclusions and recommendations.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2007-05-25

3.  Revised BCG vaccination guidelines for infants at risk for HIV infection.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2007-05-25

Review 4.  Second IUATLD study on complications induced by intradermal BCG-vaccination.

Authors:  A Lotte; O Wasz-Hockert; N Poisson; H Engbaek; H Landmann; U Quast; B Andrasofszky; L Lugosi; I Vadasz; P Mihailescu
Journal:  Bull Int Union Tuberc Lung Dis       Date:  1988-06

Review 5.  Disseminated bacille Calmette-Guérin disease after vaccination: case report and review.

Authors:  E A Talbot; M D Perkins; S F Silva; R Frothingham
Journal:  Clin Infect Dis       Date:  1997-06       Impact factor: 9.079

6.  Immune reconstitution syndrome due to bacillus Calmette-Guérin after initiation of antiretroviral therapy in children with HIV infection.

Authors:  Thanyawee Puthanakit; Penninah Oberdorfer; Suchart Punjaisee; Pornphun Wannarit; Thira Sirisanthana; Virat Sirisanthana
Journal:  Clin Infect Dis       Date:  2005-08-30       Impact factor: 9.079

7.  Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis.

Authors:  L C Rodrigues; V K Diwan; J G Wheeler
Journal:  Int J Epidemiol       Date:  1993-12       Impact factor: 7.196

8.  The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children.

Authors:  Anneke C Hesseling; Ben J Marais; Robert P Gie; H Simon Schaaf; Paul E M Fine; Peter Godfrey-Faussett; Nulda Beyers
Journal:  Vaccine       Date:  2006-08-01       Impact factor: 3.641

9.  Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness.

Authors:  B Bourdin Trunz; Pem Fine; C Dye
Journal:  Lancet       Date:  2006-04-08       Impact factor: 79.321

10.  Postpartum tuberculosis incidence and mortality among HIV-infected women and their infants in Pune, India, 2002-2005.

Authors:  Amita Gupta; Uma Nayak; Malathi Ram; Ramesh Bhosale; Sandesh Patil; Anita Basavraj; Arjun Kakrani; Sheeja Philip; Dipali Desai; Jayagowri Sastry; Robert C Bollinger
Journal:  Clin Infect Dis       Date:  2007-06-04       Impact factor: 9.079
View more
  13 in total

1.  Immunogenicity of BCG in HIV-exposed and non-exposed infants following routine birth or delayed vaccination.

Authors:  A C Hesseling; H B Jaspan; G F Black; N Nene; G Walzl
Journal:  Int J Tuberc Lung Dis       Date:  2015-04       Impact factor: 2.373

2.  Delayed BCG vaccination results in minimal alterations in T cell immunogenicity of acellular pertussis and tetanus immunizations in HIV-exposed infants.

Authors:  Anna K Blakney; Christophe Toukam Tchakoute; Anneke C Hesseling; Elvis B Kidzeru; Christine E Jones; Jo-Ann S Passmore; Donald L Sodora; Clive M Gray; Heather B Jaspan
Journal:  Vaccine       Date:  2015-08-07       Impact factor: 3.641

3.  Balancing Trained Immunity with Persistent Immune Activation and the Risk of Simian Immunodeficiency Virus Infection in Infant Macaques Vaccinated with Attenuated Mycobacterium tuberculosis or Mycobacterium bovis BCG Vaccine.

Authors:  Kara Jensen; Myra Grace Dela Pena-Ponce; Michael Piatak; Rebecca Shoemaker; Kelli Oswald; William R Jacobs; Glenn Fennelly; Carissa Lucero; Katie R Mollan; Michael G Hudgens; Angela Amedee; Pamela A Kozlowski; Jacob D Estes; Jeffrey D Lifson; Koen K A Van Rompay; Michelle Larsen; Kristina De Paris
Journal:  Clin Vaccine Immunol       Date:  2017-01-05

4.  Delaying BCG vaccination until 8 weeks of age results in robust BCG-specific T-cell responses in HIV-exposed infants.

Authors:  Christophe Toukam Tchakoute; Anneke C Hesseling; Elvis B Kidzeru; Hoyam Gamieldien; Jo-Ann S Passmore; Christine E Jones; Clive M Gray; Donald L Sodora; Heather B Jaspan
Journal:  J Infect Dis       Date:  2014-08-08       Impact factor: 5.226

5.  Getting to 90-90-90 in paediatric HIV: What is needed?

Authors:  Mary-Ann Davies; Jorge Pinto; Marlène Bras
Journal:  J Int AIDS Soc       Date:  2015-12-02       Impact factor: 5.396

Review 6.  In silico analysis and experimental validation of Mycobacterium tuberculosis -specific proteins and peptides of Mycobacterium tuberculosis for immunological diagnosis and vaccine development.

Authors:  Abu Salim Mustafa
Journal:  Med Princ Pract       Date:  2013-08-31       Impact factor: 1.927

7.  Early versus late BCG vaccination in HIV-1-exposed infants in Uganda: study protocol for a randomized controlled trial.

Authors:  Victoria Nankabirwa; James K Tumwine; Olive Namugga; Thorkild Tylleskär; Grace Ndeezi; Bjarne Robberstad; Mihai G Netea; Halvor Sommerfelt
Journal:  Trials       Date:  2017-03-31       Impact factor: 2.279

8.  Two doses of candidate TB vaccine MVA85A in antiretroviral therapy (ART) naïve subjects gives comparable immunogenicity to one dose in ART+ subjects.

Authors:  Tandakha N Dieye; Birahim P Ndiaye; Alle B Dieng; Marema Fall; Nathaniel Brittain; Nathaniel Britain; Samantha Vermaak; Makhtar Camara; Halimatou Diop-Ndiaye; Ndeye Fatou Ngom-Gueye; Papa A Diaw; Coumba Toure-Kane; Papa S Sow; Souleymane Mboup; Helen McShane
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240

9.  Rifampin-resistant Mycobacterium bovis BCG-induced disease in HIV-infected infant, Vietnam.

Authors:  Duc Nguyen Hong; Mai Nguyet Thu Huyen; Nguyen Thi Ngoc Lan; Nguyen Huy Duong; Vi Vi Nguyen Ngo; Duong Tran Ngoc; Khanh Truong Huu; Tuyen Nguyen; Viet Do Chau; Oliver Marcy; Philippe Van de Perre; Anne-Laure Bañuls; Sylvain Godreuil
Journal:  Emerg Infect Dis       Date:  2013-07       Impact factor: 6.883

Review 10.  Tuberculosis: opportunities and challenges for the 90-90-90 targets in HIV-infected children.

Authors:  Helena Rabie; Lisa Frigati; Anneke C Hesseling; Anthony J Garcia-Prats
Journal:  J Int AIDS Soc       Date:  2015-12-02       Impact factor: 5.396
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.